Evidence map›Paper›PMID 24475398›Full record

ArticleJournal of nephropathology2012

Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study.

Mahmoud Rafieian-Kopaei, Hamid Nasri, Mehdi Nematbakhsh, Azar Baradaran, Alaleh Gheissari, Hamid Rouhi, Seyed Mohammad Ahmadi Soleimani, Milad Baradaran-Ghahfarokhi, Fatemeh Ghaed-Amini, Mohammadreza Ardalan

Open access · goldAbstract read
In one paragraph

Article in Journal of nephropathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesAsian Pacific journal of cancer prevention : APJCP · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Re: Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2014
    Article
  9. Article
  10. Erythropoietin and renal protection.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Oxidative stress and the paradoxical effects of antioxidants.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mahmoud Rafieian-KopaeiMedical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Hamid NasriDepartment of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mehdi NematbakhshWater and Electrolytes Research Center, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Azar BaradaranDepartment of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan , Iran.
Alaleh GheissariIsfahan Kidney Disease Research Center, Isfahan University of Medical Sciences, Isfahan , Iran.
Hamid RouhiMedical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Seyed Mohammad Ahmadi SoleimaniDepartment of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Milad Baradaran-GhahfarokhiMedical Physics and Medical Engineering Department, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemeh Ghaed-AminiMedical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mohammadreza ArdalanDepartment of Nephrology, Tabriz University of Medical Sciences, Tabriz, Iran.
Isfahan University of Medical Sciences · IRShahrekord University of Medical Sciences · IRTabriz University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvestigations have attempted to modify the outcome of tubular injury by either ameliorating renal tubular damage or promoting tubular regeneration in the case of acute tubular necrosis.

objectivesWe investigated the protective effect of Eprex an erythropoietin analogue on tubular injury induced by gentamicin (GM). MATERIALS AND

methodsForty male Wistar rats were randomly divided into four groups. In group 1,rats were served as a sham group. In group 2, rats were injected intraperitoneally with 100 mg/kg of GM for 10 consecutive days (positive control group) and then were sacrificed. In group 3, rats received GM for 10 days then Eprex 100U/kg was injected intraperitoneally for the next 10 days and then they were sacrificed at the day 20th. In group 4 rats were injected a combination of GM (80 mg/kg) and Eprex 100U/kg intraperitoneally for 10 days and then were sacrificed.

resultsThe results indicated that, Eprex prevented the increase in serum creatinine (Cr) and blood urea nitrogen (BUN). The effect of Eprex on damage score, showed that co-administration of GM and Eprex (group 3 and 4) reduced the kidney tissue damage compared to positive control group (P<0.05). This result indicat that Eprex potentially can reduce or prevent the kidney tissue damage.

conclusionsAmeliorative effect of Eprex when the drug was given in combination with GM and also when the drug was applied after GM-induced tubular damage, revealed the renoprotective potency of Eprex. Eprex is a promising drug to prevent or attenuate tubular damage induced by GM or other nephrotoxic agents which act through the same mechanisms as gentamicin.

Indexed as

ErythropoietinGentamicinTubular toxicity

Identifiers

PMID24475398
PMCPMC3886131
OpenAlexW2154931028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.